NCT04131673

Brief Summary

This is a prospective study that aims to collect and review neuromyelitis optica spectrum disorder (NMOSD) data from African American patients with a known diagnosis of multiple sclerosis (MS). It is an investigational study, prospective in nature. No randomization of patients will be done. Information collected includes: Age, gender, age at diagnosis, MRI data (access to images), clinical presentation, findings on clinical examination, lab (blood and evoked potentials) and LP test results, eye exam findings if any and treatment, if started. Additional details may include other NEUROLOGICAL diseases which are also diagnosed (if any).

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 5, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 14, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 18, 2019

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

November 14, 2022

Status Verified

November 1, 2022

Enrollment Period

4.5 years

First QC Date

October 14, 2019

Last Update Submit

November 9, 2022

Conditions

Keywords

multiple sclerosisMSNeuromyelitis optica spectrum disorderNMOSDAfrican Americans

Outcome Measures

Primary Outcomes (1)

  • Clinical data collection and comparison

    Collect patient age, sex, date of birth, and date of diagnosis to examine trends among this population.

    Through study completion, average duration of four years

Secondary Outcomes (2)

  • MRI analysis

    Through study completion, average duration of four years

  • Diagnostic tests collection and comparison

    Through study completion, average duration of four years

Study Arms (1)

African Americans with MS

African American patients seen in the University of Kentucky's Multiple Sclerosis Clinic between the ages of 18 and 80 who have been diagnosed with MS

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

African American patients who have been diagnosed with MS and later diagnosed as having NMOSD. They will be patients that have been seen in the Kentucky Neuroscience Institute (KNI). The age range will be 18-80.

You may qualify if:

  • between the ages of 18 and 80
  • are African-American
  • have a diagnosis of MS and later diagnosis of NMOSD
  • have been seen at the University of Kentucky's Kentucky Neuroscience Institute

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kentucky

Lexington, Kentucky, 40536, United States

Location

MeSH Terms

Conditions

Multiple SclerosisNeuromyelitis Optica

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesMyelitis, TransverseOptic NeuritisOptic Nerve DiseasesCranial Nerve DiseasesEye Diseases

Study Officials

  • Jagannadha Avasarala, MD PhD

    University of Kentucky

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor of Neurology

Study Record Dates

First Submitted

October 14, 2019

First Posted

October 18, 2019

Study Start

July 5, 2019

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

November 14, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations